Ruhr-Universität Bochum

Neuroanatomie und Molekulare Hirnforschung

Dr. Mária Schneider-Lódi

Wissenschaftliche Mitarbeiterin

Ruhr-Universität Bochum
Institut für Anatomie
Abteilung für Neuroanatomie und Molekulare Hirnforschung

Publications

  • Nagy L, Gödény I, Nánási P, Leskó Á, Balogh L, Bánhegyi V, Bódi B, Csípő T,, Csongrádi A, Fülöp GÁ, Kovács Á, Lódi M, Papp Z. Inotropic therapy with the myosin activator omecamtiv mecarbil. Cardiol. Hung 2017;47(1), 145-152. [Ungarisch]
  • Nagy CA,Lódi M, Balogh I, Czuriga D, Kocsis J. New recommendations in oncocardiology Magy Onkol. 2017 Sep 20;61(3):219-227 [Ungarisch]
  • Gulácsi-Bárdos P, Szokol M, Lódi M, Czuriga D, Czuriga I, Édes I, Nagy A, Sármán B Ischaemic heart disease in cancer patients. Questions and problems Orv Hetil. 2017 Oct;158(43):1691-1697 [Ungarisch]
  • Lódi,M.; Priksz,D.; Fülöp,G.A.; Bódi,B.; Gyöngyösi,A.; Nagy,L.; Kovács,Á.; Kertész,A.B.; Kocsis,J.; Édes,I.; Csanádi,Z.; Czuriga,I.; Kisvárday,Z.; Juhász,B.; Lekli,I.; Bai,P.; Tóth,A.; Papp,Z.; Czuriga,D. Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy J.Transl.Med., 2019, 17, 1, 229-019-1978-0
  • Herwig M, Kolijn D, Lódi M, Hölper S, Kovács Á, Papp Z, Jaquet K, Haldenwang P, Dos Remedios C, Reusch PH, Mügge A, Krüger M, Fielitz J, Linke WA, Hamdani N. Modulation of Titin-Based Stiffness in Hypertrophic Cardiomyopathy via Protein Kinase D. Front Physiol. 2020 Apr 15;11:240.
  • Kolijn D, Kovács Á, Herwig M, Lódi M, Sieme M, Alhaj A, Sandner P, Papp Z, Reusch PH, Haldenwang P, Falcão-Pires I, Linke WA, Jaquet K, Van Linthout S, Mügge A, Tschöpe C, Hamdani N. Enhanced Cardiomyocyte Function in Hypertensive Rats With Diastolic Dysfunction and Human Heart Failure Patients After Acute Treatment With Soluble Guanylyl Cyclase (sGC) Activator. Front Physiol. 2020 May 25;11:345.
  • Reil JC, Reil GH, Kovács Á, Sequeira V, Waddingham MT, Lodi M, Herwig M, Ghaderi S, Kreusser MM, Papp Z, Voigt N, Dobrev D, Meyhöfer S, Langer HF, Maier LS, Linz D, Mügge A, Hohl M, Steendijk P, Hamdani N. CaMKII activity contributes to homeometric autoregulation of the heart: A novel mechanism for the Anrep effect. J Physiol. 2020 Aug;598(15):3129-3153.
  • Lódi M, Bánhegyi V, Bódi B, Gyöngyösi A, Kovács Á, Árokszállási A, Hamdani N, Fagyas M, Édes I, Csanádi Z, Czuriga I, Kisvárday Z, Lekli I, Bai P, Tóth A, Papp Z, Czuriga D. Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy. J Transl Med. 2020 Dec 9;18(1):470.
  • Kolijn D, Pabel S, Tian Y, Lódi M, Herwig M, Carrizzo A, Zhazykbayeva S, Kovács Á, Fülöp GÁ, Falcão-Pires I, Reusch PH, Linthout SV, Papp Z, van Heerebeek L, Vecchione C, Maier LS, Ciccarelli M, Tschöpe C, Mügge A, Bagi Z, Sossalla S, Hamdani N. Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation. Cardiovasc Res. 2021 Jan 21;117(2):495-507.
  • Bánhegyi V, Enyedi A, Fülöp GÁ, Oláh A, Siket IM, Váradi C, Bottyán K, Lódi M, Csongrádi A, Umar AJ, Fagyas M, Czuriga D, Édes I, Pólos M, Merkely B, Csanádi Z, Papp Z, Szabó G, Radovits T, Takács I, Tóth A. Human Tissue Angiotensin Converting Enzyme (ACE) Activity Is Regulated by Genetic Polymorphisms, Posttranslational Modifications, Endogenous Inhibitors and Secretion in the Serum, Lungs and Heart. Cells. 2021 Jul 6;10(7):1708.
  • Budde H, Hassoun R, Tangos M, Zhazykbayeva S, Herwig M, Varatnitskaya M, Sieme M, Delalat S, Sultana I, Kolijn D, Gömöri K, Jarkas M, Lódi M, Jaquet K, Kovács Á, Mannherz HG, Sequeira V, Mügge A, Leichert LI, Sossalla S, Hamdani N. The Interplay between S-Glutathionylation and Phosphorylation of Cardiac Troponin I and Myosin Binding Protein C in End-Stage Human Failing Hearts. Antioxidants (Basel). 2021 Jul 16;10(7):1134.
  • Hassoun R, Budde H, Mannherz HG, Lódi M, Fujita-Becker S, Laser KT, Gärtner A, Klingel K, Möhner D, Stehle R, Sultana I, Schaaf T, Majchrzak M, Krause V, Herrmann C, Nowaczyk MM, Mügge A, Pfitzer G, Schröder RR, Hamdani N, Milting H, Jaquet K, Cimiotti D. De Novo Missense Mutations in TNNC1 and TNNI3 Causing Severe Infantile Cardiomyopathy Affect Myofilament Structure and Function and Are Modulated by Troponin Targeting Agents. Int J Mol Sci. 2021 Sep 6;22(17):9625.
  • Hassoun R, Budde H, Zhazykbayeva S, Herwig M, Sieme M, Delalat S, Mostafi N, Gömöri K, Tangos M, Jarkas M, Pabel S, Bruckmüller S, Skrygan M, Lódi M, Jaquet K, Sequeira V, Gambichler T, Remedios CD, Kovács Á, Mannherz HG, Mügge A, Sossalla S, Hamdani N. Stress activated signalling impaired protein quality control pathways in human hypertrophic cardiomyopathy. Int J Cardiol. 2021 Dec 1;344:160-169.
  • Hassoun R, Budde H, Zhazykbayeva S, Herwig M, Sieme M, Delalat S, Mostafi N, Gömöri K, Tangos M, Jarkas M, Pabel S, Bruckmüller S, Skrygan M, Lódi M, Jaquet K, Sequeira V, Gambichler T, Remedios CD, Kovács Á, Mannherz HG, Mügge A, Sossalla S, Hamdani N. Do they come together? Protein quality control, stress-activated signaling, and „sarcostat“ in hypertrophic cardiomyopathy progression. Int J Cardiol. 2022 Jan 15;347:44-45.
  • Tangos M, Budde H, Kolijn D, Sieme M, Zhazykbayeva S, Lódi M, Herwig M, Gömöri K, Hassoun R, Robinson EL, Meister TL, Jaquet K, Kovács Á, Mustroph J, Evert K, Babel N, Fagyas M, Lindner D, Püschel K, Westermann D, Mannherz HG, Paneni F, Pfaender S, Tóth A, Mügge A, Sossalla S, Hamdani N. SARS-CoV-2 infects human cardiomyocytes promoted by inflammation and oxidative stress. Int J Cardiol. 2022 Sep 1;362:196-205. doi: 10.1016/j.ijcard.2022.05.055.
Nach oben scrollen
Skip to content